Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells

Gynecologic Oncology

Volumn 121, Issue 1, 2011, Pages 200-205

  Chen, Jing ^a   Wang, Lijuan ^a   Matyunina, Lilya V ^a   Hill, Christopher G ^a   McDonald, John F ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

EMT; MET; Metastasis; MicroRNAs; Ovarian cancer

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 200; MICRORNA 429; UNCLASSIFIED DRUG; UVOMORULIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTASIS; METASTASIS POTENTIAL; MICROARRAY ANALYSIS; MULTIGENE FAMILY; OVARY CANCER; PERITONEAL CAVITY; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 79952815913     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.12.339     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics. CA Cancer J Clin 2008;5:71-96.
2. Ahmed N, Thompson EW, Quinn MA. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol 2007;21:581-8. (Pubitemid 350058249)
3. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E. Epithelial-mesenchymal transition. Cancer Res 2008;68:9574-7.
4. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, et al. Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 2009;101:293-9.
5. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
6. Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Foutnier I, et al. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 2010;291:59-66.
7. Monteiro J, Fodde R. Cancer stemness and metastasis: therapeutic consequences and perspectives. Eur J Cancer 2010;46:1198-203.
8. Aiger K, Dampier B, Mikula M, Sultan A, Schreiber M, Mikulits W, et al. The transcriptional factor ZEB1 promotes tumor cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007;26:6979-88. (Pubitemid 350014612)
9. Spaderna S, Schmalhofer O, Wahlbuhl M, Dimmler A, Bauer K, Sultan A, et al. The transcriptional suppressor ZEB1 promotes metastasis and loss of cell polarity in cancer. Cancer Res 2008;68:537-44. (Pubitemid 351380082)
10. Park S-M, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008;22:894-907. (Pubitemid 351482843)
11. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SP1. Nat Cell Biol 2008;10:593-601. (Pubitemid 351627379)
12. Gregory PA, Bracken CP, Bert AG, Goodall GJ. MicroRNAs as regulators of epithelial-mesenchymal transitions. Cell Cycle 2008;7:3112-8.
13. Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol 2008;5:115-9.
14. Paterson EL, Kolesnikoff N, Gregory PA, Bert AG, Khew-Goodall Y, Goodall GL. The microRNA-200 family regulates epithelial to mesenchymal transition. Sci World J 2008;8:901-4.
15. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, et al. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 1983;43:5379-89. (Pubitemid 14230154)
16. Buick RN, Pullano R, Trent JM. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 1985;45:3668-76. (Pubitemid 15226443)
17. Bowen NJ, Walker LD, Matyunina LV, Logani S, Totten KA, Benigno BB, et al. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics 2009;2:71.
18. Shaw TJ, Senterman MK, Dawson K, Crane CA, Vanderhyden BC. Characterization on intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Mol Ther 2004;10:1032-42. (Pubitemid 39625247)
19. Schaar DG, Medina DJ, Moore DF, Strair RK, Ting Y. miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Exp Hematol 2009;37:245-55.
20. Soltermann A, Tischler V, Arbogast S, Braun J, Probst-Hensch N, Weder W, et al. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 2008;14:7430-7.
21. Huang H, Sossey-Alaoui K, Beachy SH, Geradts J. The tetraspanin superfamily member NET-6 is a new tumor suppressor gene. J Cancer Res Clin Oncol 2007;133:761-9. (Pubitemid 47319242)
22. Moreno-Bueno G, Cubillo E, Sarrió D, Peinado H, Rodríguez-Pinilla SM, Villa S, et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 2006;66:9543-56.
23. Sarrió D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008;68:989-97. (Pubitemid 351272216)
24. Huang Y, Fernandez SV, Goodwin S, Russo PA, Russo IH, Sutter TR, et al. Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res 2007;67:11147-57. (Pubitemid 350248539)
25. Meyer EW, Peppers J, Meyer Jr RA. Comparison of mRNA gene expression by RT-PCR and DNA microarrays. Biotechniques 2004;36:618-20.
26. Takeyama Y, Sato M, Horio M, Hase T, Yoshida K, Yokoyama T, et al. Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Lett 2010;96:216-24.
27. Ambros V. The functions of animal microRNAs. Nature 2004;16:350-5. (Pubitemid 39265675)
28. Hu X, Macdonald DM, Huettner PC, Feng Z, El Naqa IM, Schwarz JK, et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol 2009;114:457-64.
29. Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O'Briant KC, et al. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol 2010;116:117-25.
30. Chai J, Modak C, Mouazzen W, Narvaez R, Pham J. Epithelial or mesenchymal: where to draw the line? BioSci Trends 2010;4:130-42.